Pain News and Research

Latest Pain News and Research

Drug 'addicted' newborn the latest hysteria driven absurdity

The Florida Society of Pain Management Providers (www.Flspmp.org) feels it is vital to set the factual record straight in light of the mass deception used to foment a hysteria driven war on pain medications that now is threatening the health and welfare of Florida's chronic pain patients.

21 Feb 2012

Mothers who suffer migraine headaches more likely to have babies with colic

A study of mothers and their young babies by neurologists at the University of California, San Francisco (UCSF) has shown that mothers who suffer migraine headaches are more than twice as likely to have babies with colic than mothers without a history of migraines.

21 Feb 2012

ZirMed launches VeraFund Manager for healthcare providers

ZirMed, a preeminent provider of revenue cycle and information solutions for healthcare, today announced the launch of VeraFund Manager for healthcare providers. Available exclusively from ZirMed and utilizing advanced payment and remittance processing support from BNY Mellon, the service delivers an end-to-end automated patient/payer solution for healthcare providers.

20 Feb 2012

Belkin, Peerless partner to provide PeerCare EMR Hybrid Cart

Belkin today announced a strategic partnership with Peerless Industries, Inc., a designer, manufacturer and distributor of audio-visual solutions. The partnership will initially yield the PeerCare Electronic Medical Records (EMR) Hybrid Cart, fitted with a unique modular battery power system.

20 Feb 2012

Massive infant Tylenol recall

Johnson & Johnson has announced the recall of its entire U.S. supply of infants' Tylenol—about 574,000 bottles—due to a design flaw. The flaw involved bottles of grape-flavoured infants' Tylenol, which had only just returned to shelves in November announced J&J last Friday.

20 Feb 2012

EC approves Plexxikon's Zelboraf to treat BRAF mutation-positive MM

Plexxikon Inc., a member of Daiichi Sankyo Group, today announced that the European Commission has approved Zelboraf (vemurafenib) for the monotherapy treatment of adult patients with BRAFV600 mutation-positive unresectable or metastatic melanoma.

20 Feb 2012

Modified imatinib cancer drug prevents morphine tolerance in rats

By reformulating the common cancer drug imatinib (Gleevec), researchers have eliminated morphine tolerance in rats - an important step toward improving the effectiveness of chronic pain management in patients, according to researchers at The University of Texas MD Anderson Cancer Center.

20 Feb 2012

Researchers discover class of proteins that detect 'painful touch'

In two landmark papers in the journal Nature this week, scientists at The Scripps Research Institute report that they have identified a class of proteins that detect "painful touch."

19 Feb 2012

Remote controlled microchip successfully delivers drug in early clinical trial

Researchers have developed a new microchip implant device that can deliver bone-building drugs to seven osteoporosis patients. The microchips worked inside patients as drug-delivering pacemakers, following a prescription plan sent by radio signal.

18 Feb 2012

Mobius selects The Apothecary Shops as distribution partner for Mitosol Kit for Ophthalmic Use

Apothecary Shop Wholesale, Inc., an affiliate of The Apothecary Shops Specialty Pharmacies, has received exclusive distribution rights from Mobius Therapeutics, LLC for its new drug Mitosol (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use.

18 Feb 2012

FSMB initiatives to raise awareness about opioid prescribing

The Federation of State Medical Boards (FSMB) announced today several initiatives aimed at addressing the rise of opioid abuse and related deaths in the United States, while safeguarding legitimate access to medications for patients with pain.

18 Feb 2012

Common misconceptions about brain and severity of head injuries

According to the Centers for Disease Control, sports-related concussions are an epidemic in this country. With more than three million sports-related concussions happening every year, research shows the effects can be long-lasting, even leading to permanent brain damage and early onset of dementia. Dr. Howard Derman, director of the Methodist Concussion Center in Houston, shares some of the common misconceptions about the brain and the severity of head injuries.

18 Feb 2012

Innocoll completes XaraColl End-of-Phase 2 meeting with FDA

Innocoll, Inc. announced that it has held an End-of-Phase 2 meeting with the FDA to present the results of the Phase 2 clinical studies completed for XaraColl and to discuss the proposed safety and efficacy studies to be conducted in Phase 3. XaraColl is being developed for postoperative analgesia and Innocoll plans to undertake its Phase 3 program in patients undergoing hernia repair.

17 Feb 2012

Pharmos reports net loss of $0.4 million for fourth quarter 2011

Pharmos Corporation reported financial results for the fourth quarter and twelve-month period ended December 31, 2011. These results are included in the Company's Yearly Report on Form 10-K which has been filed with the SEC.

17 Feb 2012

FDA approves Medtronic's Resolute Integrity DES to treat CAD

Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.

From Medtronic 17 Feb 2012

Web-based intervention can effectively manage chronic migraine

painACTION.com is a free, non-promotional online program designed to support self-management and improve overall function in people with chronic pain. This study tested painACTION.com's ability to increase the use of self-management skills in people with chronic migraine headaches.

17 Feb 2012

Nordion celebrates first anniversary of market launch of TheraSphere

Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.

17 Feb 2012

AstraZeneca launches ARIMIDEX Direct to help cancer patients

AstraZeneca today announced its first-ever direct-to-patient program offering patients with a valid prescription for ARIMIDEX or anastrozole the opportunity to have the brand ARIMIDEX delivered directly to their home by Express Scripts, a specialty pharmacy services provider, for $40 per month, including shipping.

17 Feb 2012

Cryoablation increases survival rates in ovarian cancer patients

Ovarian cancer, which killed 15,000 American women last year, is one of the deadliest forms of cancer. A team of Wayne State University School of Medicine researchers recently proved that freezing tumors increases survival rates in ovarian cancer patients.

17 Feb 2012

Hospital news: Colorado legislature considers limits on charges, Philly children's hospital apology, Mass. facility closure

Colorado's legislature is taking up a bill Thursday that would limit how much hospitals can charge people without insurance. ... The lawmaker who wrote it is trying to reduce the number of Coloradans bankrupted by medical bills.

16 Feb 2012